X
Please Wait
Applying Filters...
01 TEVA WOMENS (7)
01 TABLET;ORAL (7)
01 DISCN (7)
01 ADDERALL 10 (1)
02 ADDERALL 12.5 (1)
03 ADDERALL 15 (1)
04 ADDERALL 20 (1)
05 ADDERALL 30 (1)
06 ADDERALL 5 (1)
07 ADDERALL 7.5 (1)
01 Yes (7)
19
Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 11522.
Regulatory Information DISCN
With a dosage strength 3.125MG;3.125MG;3.125MG;3.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2000-08-31
18
Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 11522.
Regulatory Information DISCN
With a dosage strength 7.5MG;7.5MG;7.5MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1997-05-12
17
Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 11522.
Regulatory Information DISCN
With a dosage strength 5MG;5MG;5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1996-02-13
16
Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 11522.
Regulatory Information DISCN
With a dosage strength 3.75MG;3.75MG;3.75MG;3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2000-08-31
15
Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 11522.
Regulatory Information DISCN
With a dosage strength 1.875MG;1.875MG;1.875MG;1.875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2000-08-31
14
Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 11522.
Regulatory Information DISCN
With a dosage strength 1.25MG;1.25MG;1.25MG;1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1997-05-12
13
Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 11522.
Regulatory Information DISCN
With a dosage strength 2.5MG;2.5MG;2.5MG;2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1996-02-13
Market Place
